Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-003289-16Phase 2Completed
Phase 2, randomised, double-blind trial in hepatitis C virus infection comparing TMC435350 arm with Placebo arm (2 arms). Primary endpoints: Primary antiviral efficacy endpoint, Safety and tolerability and 1 more. Started Oct 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-003289-16.